Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency-Reference-Cited by-同舟云学术

Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency

Published:2018-02-22 Issue:8 Volume:131 Page:917-931
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Fox Thomas A.¹²,Chakraverty Ronjon²³⁴,Burns Siobhan¹²³,Carpenter Benjamin²⁵,Thomson Kirsty²⁴,Lowe David¹⁶,Fielding Adele²³⁴,Peggs Karl²⁴,Kottaridis Panagiotis²³,Uttenthal Benjamin⁷,Bigley Venetia⁸,Buckland Matthew¹⁶,Grandage Victoria⁵,Denovan Shari²³⁵,Grace Sarah²³⁵,Dahlstrom Julia²⁵,Workman Sarita⁶,Symes Andrew⁶,Mackinnon Stephen²³⁴,Hough Rachael⁵,Morris Emma¹²⁶^ORCID

Affiliation:

1. Institute of Immunity and Transplantation, University College London (UCL), London, United Kingdom;

2. Bone Marrow Transplant (BMT) Programme, UCL Hospital National Health Service Foundation Trust (NHS FT), London, United Kingdom;

3. Department of Haematology, Royal Free London NHS FT, London, United Kingdom;

4. Department of Haematology, Cancer Institute, UCL, London, United Kingdom;

5. Teenage and Young Adult BMT Programme, UCL Hospital NHS FT, London, United Kingdom;

6. Department of Immunology, Royal Free London NHS FT, London, United Kingdom;

7. Department of Haematology, Addenbrookes’ Hospital, Cambridge, United Kingdom; and

8. Institute of Cellular Medicine, Newcastle University, Newcastle, United Kingdom

Abstract

Key Points Allo-HSCT with RIC is safe and effective in younger adults with severe PID. Referral triggers should include severe infections, autoimmunity, malignancy, and disease progression despite conservative management.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/131/8/917/1466640/blood807487.pdf

Reference39 articles.

1. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome;Bach;Lancet,1968

2. Immunological reconstitution of sex-linked lymphopenic immunological deficiency;Gatti;Lancet,1968

3. European experience of bone-marrow transplantation for severe combined immunodeficiency;Fischer;Lancet,1990

4. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency;Fischer;Blood,1994

5. Hematopoietic stem cell transplantation for primary immunodeficiency diseases;Slatter;Ann N Y Acad Sci,2011

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity;Blood;2024-08-01

2. Functional genomics in inborn errors of immunity;Immunological Reviews;2024-02-08

3. Inborn Errors of Immunity;The EBMT Handbook;2024

4. The PID Odyssey 2030: outlooks, unmet needs, hurdles, and opportunities — proceedings from the IPOPI global multi-stakeholders’ summit (June 2022);Frontiers in Immunology;2023-08-15

5. Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease;Frontiers in Immunology;2023-06-05